NCT03678883Phase 2Active not recruiting

9-ING-41 in Patients With Advanced Cancers

Study sponsor: Actuate Therapeutics Inc. · ACTU

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-06Estimated
Enrollment · participants350Estimated
Source updated2026-04-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jan 2025. After: Jun 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview